The Academy of Managed Care Pharmacy (AMCP) thanks the Office of Management and Budget (OMB) for the opportunity to provide comments in response to the proposed rule titled Regulation for Federal Financial Assistance.
On May 21, the House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a hearing titled: “Medicines and IP: Balancing Innovation and Access.” The hearing examined policies and issues around the United States patent system, generic and biosimilar drug competition under the Hatch-Waxman Act, and maintaining domestic innovation in the drug development space.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.